Monthly costs of select new cancer drugs 2016
This statistic displays the monthly treatment costs for some of the most recent cancer drugs in the United States, as of May 2016. Cancer drug nivolumab, also known under the trade name Opdivo, had monthly treatment costs ranging between six and 13 thousand U.S. dollars.